Correlation
The correlation between ASND and FINV is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
ASND vs. FINV
Compare and contrast key facts about Ascendis Pharma A/S (ASND) and FinVolution Group (FINV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ASND or FINV.
Performance
ASND vs. FINV - Performance Comparison
Loading data...
Key characteristics
ASND:
0.65
FINV:
1.96
ASND:
1.43
FINV:
2.66
ASND:
1.16
FINV:
1.35
ASND:
0.85
FINV:
1.62
ASND:
3.02
FINV:
7.79
ASND:
10.80%
FINV:
10.85%
ASND:
46.46%
FINV:
42.50%
ASND:
-61.72%
FINV:
-89.64%
ASND:
-3.87%
FINV:
-18.59%
Fundamentals
ASND:
$10.63B
FINV:
$2.13B
ASND:
-$6.59
FINV:
$1.38
ASND:
28.83
FINV:
0.16
ASND:
14.55
FINV:
0.99
ASND:
$368.70M
FINV:
$13.36B
ASND:
$314.50M
FINV:
$10.72B
ASND:
-$245.31M
FINV:
$4.86B
Returns By Period
The year-to-date returns for both investments are quite close, with ASND having a 27.62% return and FINV slightly higher at 28.54%.
ASND
27.62%
2.11%
31.59%
30.04%
26.74%
3.77%
26.52%
FINV
28.54%
0.12%
29.68%
82.59%
34.15%
45.30%
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ASND vs. FINV — Risk-Adjusted Performance Rank
ASND
FINV
ASND vs. FINV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Ascendis Pharma A/S (ASND) and FinVolution Group (FINV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
ASND vs. FINV - Dividend Comparison
ASND has not paid dividends to shareholders, while FINV's dividend yield for the trailing twelve months is around 3.29%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
ASND Ascendis Pharma A/S | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
FINV FinVolution Group | 3.29% | 3.49% | 4.39% | 4.13% | 3.45% | 4.49% | 7.17% |
Drawdowns
ASND vs. FINV - Drawdown Comparison
The maximum ASND drawdown since its inception was -61.72%, smaller than the maximum FINV drawdown of -89.64%. Use the drawdown chart below to compare losses from any high point for ASND and FINV.
Loading data...
Volatility
ASND vs. FINV - Volatility Comparison
Ascendis Pharma A/S (ASND) has a higher volatility of 13.65% compared to FinVolution Group (FINV) at 11.20%. This indicates that ASND's price experiences larger fluctuations and is considered to be riskier than FINV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
ASND vs. FINV - Financials Comparison
This section allows you to compare key financial metrics between Ascendis Pharma A/S and FinVolution Group. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities